Ro15-4513
Versandkostenfrei!
Versandfertig in 6-10 Tagen
30,99 €
inkl. MwSt.
PAYBACK Punkte
15 °P sammeln!
High Quality Content by WIKIPEDIA articles! Ro15-4513 is a weak partial inverse agonist of the benzodiazepine class of drugs, developed by Hoffmann La Roche in 1984, and is structurally related to the benzodiazepine antidote flumazenil. The main interest in Ro15-4513 was as an antidote to alcohol. Flumazenil effectively blocks the effects of benzodiazepine agonists such as alprazolam and diazepam and so is used for treating overdoses of these drugs but is ineffective in blocking alcohol actions. Ro15-4513 was somewhat less effective than flumazenil at blocking the effects of benzodiazepines, b...
High Quality Content by WIKIPEDIA articles! Ro15-4513 is a weak partial inverse agonist of the benzodiazepine class of drugs, developed by Hoffmann La Roche in 1984, and is structurally related to the benzodiazepine antidote flumazenil. The main interest in Ro15-4513 was as an antidote to alcohol. Flumazenil effectively blocks the effects of benzodiazepine agonists such as alprazolam and diazepam and so is used for treating overdoses of these drugs but is ineffective in blocking alcohol actions. Ro15-4513 was somewhat less effective than flumazenil at blocking the effects of benzodiazepines, but instead selectively blocked the effects of ethanol. This meant that in contrast to flumazenil, which is ineffective at treating alcohol overdoses, Ro15-4513 showed potential as a useful alcohol antidote.
Andere Kunden interessierten sich für
